Sign In
Buy ERAS
$18.15
-0.530 (-2.84%)
At Close: Jul 31, 2026
Erasca Announces Proposed Public Offering of $500 Million of Common Stock
04:19pm, Monday, 13'th Jul 2026
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for p
At RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2LKRAS G12X pancreatic cancer in U. S. trial and median relative dose intensity of 100% Monotherapy has been generally well-toler
Key Dates and Disclosure Events Shareholders Need to Know: From J.P. Morgan Conference Claims to Patent Infringement Letter and Patient Death, a 15-Month Sequence of Events Cost ERAS Investors $11.59
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their Options If you purchased or acquired
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 202
Erasca, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ERAS
04:47am, Monday, 13'th Jul 2026
LOS ANGELES, July 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Company") (NASDAQ: ERAS) for violations of §§10(b) a
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm
04:00am, Monday, 13'th Jul 2026
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm
03:41am, Monday, 13'th Jul 2026
LOS ANGELES, July 13, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Comp
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit
09:00pm, Sunday, 12'th Jul 2026
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, July 12, 202
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit
08:16pm, Sunday, 12'th Jul 2026
NEW YORK, July 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26
NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and Apri
New York, New York--(Newsfile Corp. - July 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 20
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their Options
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Ag
NEW ORLEANS, July 10, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 10, 2026 to file lead plaintiff applications in a securiti
